CLINICAL_TRIALS
withdrawal
· 2022-11-03
Clinical Trial Update: Efficacy and Safety of the Association Drugs in Patients With Allergic Dermatitis [Phase 3]
Summary
Phase 3 trial of association drugs in dermatitis was withdrawn from the study.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Azidus Brasil | Conditions: Dermatitis | Phase 3 | Status: WITHDRAWN